| Wissenschaftl. Titel | A randomized, Double-blind, Placebo-controlled, Single-and Muliple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Exploratory Clinical Activity of NM26-2198 in Healthy Japanese and Non-Asian Volunteers and in Adult Patients with Atopic Dermatitis |
| Erkrankung |
Haut:
Ekzem (Dermatitis):
Neurodermitis (Atopische Dermatitis)
|
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
| Links | Zu den EIn- und Ausschlusskriterien |
erstellt 25.01.2024 Admin03
geändert 15.02.2024 Admin02